[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343276-105":59,"doc-detail-343276-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","ccl2-signaling-promotes-skeletal-muscle-wasting-in-non-tumor-and-breast-tumor-models","CCL2 signaling promotes skeletal muscle wasting in non-tumor and breast tumor models","","Approximately 25% of breast cancer patients develop long-term skeletal muscle wasting (SMW), which limits mobility, reduces drug tolerance, and worsens survival. This study examines how the chemokine CCL2 drives SMW in tumor and non-tumor settings. In vitro, CCL2 suppresses myoblast and myotube function via CCR2-dependent pathways involving JNK, SMAD3, and AMPK. Recombinant CCL2 induces SMW in healthy mice, and breast tumor-derived CCL2 knockdown partially protects against SMW. Results support that chronic upregulated CCL2–CCR2 signaling promotes SMW and may inform therapeutic targeting.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ccl2-signaling-promotes-skeletal-muscle-wasting-in-non-tumor-and-breast-tumor-models/343276/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ccl2-signaling-promotes-skeletal-muscle-wasting-in-non-tumor-and-breast-tumor-models/343276.png","ImageObject",300,407,{"name":92,"@type":93},"Miles","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How common is skeletal muscle wasting (SMW) in breast cancer patients?","Question",{"text":113,"@type":114},"About 25% of breast cancer patients experience long-term SMW, which contributes to mobility loss, reduced drug tolerance, and poorer survival.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What is the role of CCL2 signaling in SMW according to the study?",{"text":118,"@type":114},"Upregulated, chronic CCL2–CCR2 signaling positively regulates SMW across tumor and non-tumor contexts.",{"name":120,"@type":111,"acceptedAnswer":121},"What mechanisms link CCL2 to impaired muscle cell function?",{"text":122,"@type":114},"In vitro, increasing CCL2 inhibits myoblast and myotube function through CCR2-dependent signaling involving JNK, SMAD3, and AMPK.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},343276,1790387993,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","© 2024 . Published by The Company of Biologists Ltd | Disease Models & Mechanisms (2024) 17, dmm050398 . doi:10 . 1242/dmm.050398  \nRESEARCH ARTICLE  \nCCL2 signaling promotes skeletal muscle wasting in non-tumor and breast tumor models  \nNadia Alissa1, Wei Bin Fang2, Marcela Medrano2, Nick Bergeron2, Yuuka Kozai2, Qingting Hu2,*,‡, Chloe Redding2, John Thyfault3, Jill Hamilton-Reeves4, Cory Berkland5 and Nikki Cheng1,2,6,§  \nABSTRACT  \nDespite advancements in treatment, approximately 25% of patients with breast cancer experience long-term skeletal muscle wasting (SMW), which limits mobility, reduces drug tolerance and adversely impacts survival. By understanding the underlying molecular mechanisms of SMW, we may be able to develop new strategies to alleviate this condition and improve the lives of patients with breast cancer. Chemokines are small soluble factors that regulate homing of immune cells to tissues during inflammation. In breast cancers, overexpression of C-C chemokine ligand 2 (CCL2) correlates with unfavorable prognosis. Elevated levels of CCL2 in peripheral blood indicate possible systemic effects of this chemokine in patients with breast cancer. Here, we investigated the role of CCL2 signaling on SMW in tumor and non-tumor contexts. In vitro, increasing concentrations of CCL2 inhibited myoblast and myotube function through C-C chemokine receptor 2 (CCR2)-dependent mechanisms involving JNK, SMAD3 andAMPK signaling. In healthy mice, delivery of recombinant CCL2 protein promoted SMW in a dose-dependent manner. In vivo knockdown of breast tumor-derived CCL2 partially protected against SMW. Overall, chronic, upregulated CCL2–CCR2 signaling positively regulates SMW, with implications for therapeutic targeting.  \nKEY WORDS: Breast cancer, Cachexia, Skeletal muscle wasting, Chemokine, CCL2  \nINTRODUCTION  \nBreast cancer is the most commonly diagnosed form of cancer in women in the USA, with over 260,00 cases diagnosed every year (Giaquinto et al., 2022) . Despite advancements in treatment, approximately 25% of patients with breast cancer experience long-term skeletal muscle wasting (SMW) (Mallard et al., 2021) .  \n1Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA. 2Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USA. 3Department of Cell Biology and Physiology and Internal Medicine-Division of Endocrinology, University of Kansas Medical Center, Kansas City, KS 66160, USA. 4Department of Urology, University of Kansas Medical Center, Kansas City, KS 66160, USA. 5Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66045, USA. 6University of Kansas Cancer Center, Kansas City, KS 66160, USA.  \n*Present address: Graduate Program in Genetics, Stony Brook University, Stony Brook, NY 11794, USA.‡Present address: Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.  \n§Author for correspondence ([ncheng@kumc.edu](ncheng@kumc.edu))  \n N. C. , 0000-0001-6920-3621  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution License ([https://creativecommons.org/licenses/by/4.0](https://creativecommons.org/licenses/by/4.0)), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.  \nHandling Editor: Owen Sansom  \nReceived 17 July 2023; Accepted 15 May 2024  \nSMW is a primary characteristic of cancer cachexia, a systemic wasting illness characterized by unexpected loss of body weight by ≥5% or body mass index by ≤20, along with anorexia, diminished strength and higher inflammation. SMW is associated with metastatic disease and is characterized by decreased muscle mass and strength. This contributes to increased fatigue, decreased mobility, and increased levels of anxiety and depression. Under severe circumstances, SMW impairs drug tolerance and respiration. As such, SMW has a significantl","cbCaitgq0KZUOgYH","https://ap.wps.com/l/cbCaitgq0KZUOgYH","pdf",9345168,18,"English","# Abstract\n# Introduction","[{\"question\":\"How common is skeletal muscle wasting (SMW) in breast cancer patients?\",\"answer\":\"About 25% of breast cancer patients experience long-term SMW, which contributes to mobility loss, reduced drug tolerance, and poorer survival.\"},{\"question\":\"What is the role of CCL2 signaling in SMW according to the study?\",\"answer\":\"Upregulated, chronic CCL2–CCR2 signaling positively regulates SMW across tumor and non-tumor contexts.\"},{\"question\":\"What mechanisms link CCL2 to impaired muscle cell function?\",\"answer\":\"In vitro, increasing CCL2 inhibits myoblast and myotube function through CCR2-dependent signaling involving JNK, SMAD3, and AMPK.\"}]","CCL2 signaling promotes skeletal muscle wasting in non-tumor and breast tumor models | PDF",1790050541,45,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bfbf487e3a64db02f87648c13093c9f7.webp",983,1272,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3bba1427fb05142aa434cd4fddd70f26.webp",982,1270,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/065bd4836c9f5eadd497d6d28ac79d5d.webp",981,1269,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d4842b2d2ae1e8654646272b77a7fd1d.webp",980,1268]